Qtron Investments’s BeOne Medicines Ltd ONC Stock Holding History

Qtron Investments’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$799K	Sell	2,804 -367	-12%	-$108K	0.11%	227
2026 Q1	$942K	Sell	3,171 -100	-3%	-$32.4K	0.13%	197
2025 Q4	$994K	Sell	3,271 -471	-13%	-$154K	0.13%	183
2025 Q3	$1.27M	Buy	3,742 +412	+12%	+$125K	0.16%	152
2025 Q2	$806K	Buy	3,330 +1,747	+110%	+$428K	0.1%	239
2025 Q1	$431K	Buy	+1,583	New	+$370K	0.06%	317
2024 Q2	–	Sell	-1,378	Closed	-$216K	–	505
2024 Q1	$216K	Hold	1,378	–	–	0.03%	461
2023 Q4	$249K	Sell	1,378 -296	-18%	-$53.5K	0.04%	436
2023 Q3	$301K	Buy	+1,674	New	+$331K	0.06%	361
2023 Q2	–	Sell	-4,003	Closed	-$863K	–	445
2023 Q1	$863K	Sell	4,003 -865	-18%	-$207K	0.18%	155
2022 Q4	$1.07M	Buy	4,868 +698	+17%	+$128K	0.22%	108
2022 Q3	$562K	Buy	+4,170	New	+$716K	0.14%	206
2022 Q2	–	Sell	-3,410	Closed	-$643K	–	440
2022 Q1	$643K	Hold	3,410	–	–	0.14%	203
2021 Q4	$924K	Buy	3,410 +863	+34%	+$291K	0.21%	143
2021 Q3	$925K	Buy	+2,547	New	+$833K	0.25%	119

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Qtron Investments's ONC Position: Q2 2026 in Review

Qtron Investments reduced its BeOne Medicines Ltd (ONC) stake by 12% in Q2 2026, selling an estimated $108K and leaving 2,804 shares worth $799K. The position accounts for 0.11% of the portfolio, ranked #227.

Qtron Investments first reported a position in ONC in Q3 2021 and has held it in 15 quarters since. The position peaked at $1.27M in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Qtron Investments held 2,804 shares of BeOne Medicines Ltd worth $799K as of Q2 2026.
Qtron Investments sold 367 BeOne Medicines Ltd shares in Q2 2026, an estimated $108K.
BeOne Medicines Ltd made up 0.11% of Qtron Investments's portfolio in Q2 2026, its #227 holding.
Qtron Investments first reported a position in BeOne Medicines Ltd in Q3 2021 and has held it in 15 quarters since.
Qtron Investments's BeOne Medicines Ltd position peaked at $1.27M in Q3 2025.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Qtron Investments's 13F filing for Q2 2026, filed 13 Aug 2026.